Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

October 2022: TAVI Stroke Protection, Menthol Cigs, Ukraine Cath Labs, and More

Podcast Heart Sounds

October 2022: TAVI Stroke Protection, Menthol Cigs, Ukraine Cath Labs, and More

October 26, 2022

TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Podcast TCTMD Talking Points

TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

July 01, 2020

IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI of Long Coronary Lesions

Podcast TCTMD Talking Points

IVUS-XPL: Intravascular Ultrasound-Guided vs. Angiography-Guided PCI of Long Coronary Lesions

June 17, 2020

FORZA: Randomized Trial of Fractional Flow Reserve vs Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses

Podcast TCTMD Talking Points

FORZA: Randomized Trial of Fractional Flow Reserve vs Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses

May 20, 2020

Wearables - The Future Is Now

Podcast TCTMD Talking Points

Wearables - The Future Is Now

April 21, 2020

Onyx ONE: Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Podcast TCTMD Talking Points

Onyx ONE: Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

April 15, 2020

TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin in High-Risk Patients Undergoing PCI

Podcast TCTMD Talking Points

TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin in High-Risk Patients Undergoing PCI

April 01, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.